In anti-tumor T-cell responses, large amounts of K+ produced by necrotizing tumor cells lead to a functional decline in CD8+ T cells owing to increased intracellular K+ affecting the Akt-mTOR pathway. The gene discussed is AKT1; the disease is neoplasm.